Drug Information

Drug General Information
Drug ID
D0BD3G
Former ID
DNC007755
Drug Name
4-(2-(4-chlorobenzyloxy)-5-bromobenzyl)morpholine
Drug Type
Small molecular drug
Indication Discovery agent Investigative [528511]
Formula
C18H19BrClNO2
Canonical SMILES
C1COCCN1CC2=C(C=CC(=C2)Br)OCC3=CC=C(C=C3)Cl
InChI
1S/C18H19BrClNO2/c19-16-3-6-18(23-13-14-1-4-17(20)5-2-14)15(11-16)12-21-7-9-22-10-8-21/h1-6,11H,7-10,12-13H2
InChIKey
JUKUHNUKMFGLIK-UHFFFAOYSA-N
PubChem Compound ID
11188669
Target and Pathway
Target(s) C-C chemokinereceptor type 5 Target Info Inhibitor [528511]
KEGG Pathway Cytokine-cytokine receptor interaction
Chemokine signaling pathway
Endocytosis
Toxoplasmosis
Viral carcinogenesis
NetPath Pathway TSLP Signaling Pathway
TCR Signaling Pathway
IL2 Signaling Pathway
PANTHER Pathway Inflammation mediated by chemokine and cytokine signaling pathway
Pathway Interaction Database IL12-mediated signaling events
Reactome Binding and entry of HIV virion
Chemokine receptors bind chemokines
G alpha (i) signalling events
WikiPathways TCR Signaling Pathway
GPCRs, Class A Rhodopsin-like
HIV Life Cycle
Peptide GPCRs
GPCR ligand binding
GPCR downstream signaling
GPCRs, Other
References
Ref 528511Bioorg Med Chem Lett. 2007 Jan 1;17(1):231-4. Epub 2006 Nov 1.CCR5 receptor antagonists: discovery and SAR study of guanylhydrazone derivatives.
Ref 528511Bioorg Med Chem Lett. 2007 Jan 1;17(1):231-4. Epub 2006 Nov 1.CCR5 receptor antagonists: discovery and SAR study of guanylhydrazone derivatives.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.